BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16155326)

  • 1. [Epidemiological study of functional bowel disorders in Iceland].
    Olafsdóttir LB; Gudjónsson H; Thjódleifsson B
    Laeknabladid; 2005 Apr; 91(4):329-33. PubMed ID: 16155326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior.
    Masud MA; Hasan M; Khan AK
    Am J Gastroenterol; 2001 May; 96(5):1547-52. PubMed ID: 11374697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.
    Saito YA; Locke GR; Talley NJ; Zinsmeister AR; Fett SL; Melton LJ
    Am J Gastroenterol; 2000 Oct; 95(10):2816-24. PubMed ID: 11051354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
    Boyce PM; Koloski NA; Talley NJ
    Am J Gastroenterol; 2000 Nov; 95(11):3176-83. PubMed ID: 11095338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
    Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
    Chang L
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life.
    Frankhuisen R; Van Herwaarden MA; Heijkoop R; Baron A; Vermeijden R; Smout AJ; Gooszen HG; Samsom M
    Scand J Gastroenterol; 2009; 44(6):687-91. PubMed ID: 19263270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and relation of dyspepsia to irritable bowel syndrome in a native community of the Peruvian jungle].
    Curioso WH; Donaires Mendoza N; Bacilio Zerpa C; Ganoza Gallardo C; León Barúa R
    Rev Gastroenterol Peru; 2002; 22(2):129-40. PubMed ID: 12098741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features.
    Stewart WF; Liberman JN; Sandler RS; Woods MS; Stemhagen A; Chee E; Lipton RB; Farup CE
    Am J Gastroenterol; 1999 Dec; 94(12):3530-40. PubMed ID: 10606315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
    Bommelaer G; Dorval E; Denis P; Czernichow P; Frexinos J; Pelc A; Slama A; El Hasnaoui A
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1118-23. PubMed ID: 12520200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders.
    Tuteja AK; Talley NJ; Joos SK; Tolman KG; Hickam DH
    Am J Gastroenterol; 2008 May; 103(5):1241-8. PubMed ID: 18422817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstones, cholecystectomy and irritable bowel syndrome (IBS) MICOL population-based study.
    Corazziari E; Attili AF; Angeletti C; De Santis A
    Dig Liver Dis; 2008 Dec; 40(12):944-50. PubMed ID: 18406218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep disturbances in clinic patients with functional bowel disorders.
    Fass R; Fullerton S; Tung S; Mayer EA
    Am J Gastroenterol; 2000 May; 95(5):1195-2000. PubMed ID: 10811327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life at dyspepsia and irritable bowel syndrome: population-based studies].
    Reshetnikov OV; Kurilovich SA; Simonova GI; Pylenkova ED; Maliutina SK
    Eksp Klin Gastroenterol; 2010; (3):27-31. PubMed ID: 20496786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity and use of health-care services among irritable bowel syndrome sufferers.
    Hillilä MT; Siivola MT; Färkkilä MA
    Scand J Gastroenterol; 2007 Jul; 42(7):799-806. PubMed ID: 17558902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.
    Vandvik PO; Lydersen S; Farup PG
    Scand J Gastroenterol; 2006 Jun; 41(6):650-6. PubMed ID: 16716962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.